<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02406157</url>
  </required_header>
  <id_info>
    <org_study_id>ZOC-MPLD</org_study_id>
    <nct_id>NCT02406157</nct_id>
  </id_info>
  <brief_title>577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema</brief_title>
  <official_title>Pure Yellow (577nm) Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema:A Prospective, Randomized, Paralleled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, parallel controlled, clinical-trial aims to evaluate the therapeutic
      efficacy and safety of 577nm micropulse laser photocoagulation for diabetic macular edema
      compared with 532 subthreshold laser photocoagulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. To evaluate the efficacy of 577nm micropulse laser photocoagulation with grid/focal
           treatment for diabetic macular edema.

        2. To investigate influence of 577nm micropulse laser photocoagulation on structure and
           function of macula compared with 532nm subthreshold laser photocoagulation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Best Corrected Visual Acuity(BCVA)</measure>
    <time_frame>1 year</time_frame>
    <description>Best Corrected Visual Acuity will be measured by standard Early Treatment Diabetic Retinopathy Study (ETDRS) protocol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in 10°retinal sensitivity</measure>
    <time_frame>1 year</time_frame>
    <description>Retinal sensitivity will be measured by microperimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of fundus autofluorescence</measure>
    <time_frame>1 year</time_frame>
    <description>Fundus autofluorescence will be evaluated for different patterns（normal, increased, and decreased）before and after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Central Retinal Thickness(CRT)</measure>
    <time_frame>1 year</time_frame>
    <description>Central Retinal Thickness will be performed by optical coherence tomography(OCT)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">118</enrollment>
  <condition>Diabetic Macular Edema</condition>
  <arm_group>
    <arm_group_label>577-MPL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>577nm micropulse laser photocoagulation(577MPL) treatment to the macular area of retinal thickening with a focal or grid pattern</description>
  </arm_group>
  <arm_group>
    <arm_group_label>532-SLP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>532nm subthreshold laser photocoagulation(532-SLP) treatment to the macular area of retinal thickening with a focal or grid pattern</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>577-MPL</intervention_name>
    <description>Device for 577nm micropulse treatment of the diabetic macular edema with the following parameters:100 microns spot size,5% duty cycle of 0.2 seconds,power is tested on micropulse mode and then reduce power to 50% of visible</description>
    <arm_group_label>577-MPL</arm_group_label>
    <other_name>577nm micropulse laser photocoagulation treatment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>532-SLP</intervention_name>
    <description>Device for 532nm subthreshold treatment of the diabetic macular edema, by decomposing a subthreshold short pulse, with 10 milliseconds, 100 microns, and power(100-1000mW) adjusted according to patient's diopter transparency and pigmentation</description>
    <arm_group_label>532-SLP</arm_group_label>
    <other_name>532nm subthreshold laser photocoagulation treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged ＞18 years

          -  Patients with diabetes mellitus type 2

          -  Diagnosed as diabetic retinopathy with Clinical Significant Macular Edema

          -  Central retinal thickness(CRT) of more than 250μm as measured by optical coherence
             tomography (OCT)

          -  ETDRS visual acuity ＞19 letters (Snellen equivalent of 20/400 or better)

          -  No macular laser coagulation or surgery or medicine therapy of macular edema within
             the last 6 months

          -  Blood glucose was controlled steadily(HbA1c≤10%)

        Exclusion Criteria:

          -  Taking part in other clinical trial within 3 months

          -  Planning panretinal photocoagulation(PRP) within 3 months

          -  Performed cataract surgery in the last 3 months

          -  Accompanied with other retinal vascular disease that can lead to macular edema, for
             example branch retinal vein occlusion(BRVO),central retinal vein occlusion(CRVO)

          -  Accompanied with severe opacity of refractive media that maybe impact therapy and
             observation

          -  Accompanied with nystagmus

          -  Accompanied with some history that maybe interfere with result or increase the risk of
             patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chenjin Jin</last_name>
    <role>Study Director</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lijun Zhou</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lijun Zhou</last_name>
    <phone>15626216173</phone>
    <email>zhoulijun1256@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiawei Wang</last_name>
      <phone>020-87331359</phone>
    </contact>
    <contact_backup>
      <last_name>Chenjin Jin</last_name>
      <phone>13302209900</phone>
    </contact_backup>
    <investigator>
      <last_name>Chenjin Jin</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lijun Zhou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.iovs.org/content/52/7/4314.long</url>
    <description>Randomized clinical trial evaluating modified Early Treatment Diabetic Retinopathy Study(mETDRS) versus normal or high-density micropulse photocoagulation for diabetic macular edema</description>
  </link>
  <reference>
    <citation>Lavinsky D, Cardillo JA, Melo LA Jr, Dare A, Farah ME, Belfort R Jr. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest Ophthalmol Vis Sci. 2011 Jun 17;52(7):4314-23. doi: 10.1167/iovs.10-6828.</citation>
    <PMID>21345996</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2015</study_first_submitted>
  <study_first_submitted_qc>March 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2015</study_first_posted>
  <last_update_submitted>October 12, 2017</last_update_submitted>
  <last_update_submitted_qc>October 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Jin Chen-jin</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>diabetic macular edema</keyword>
  <keyword>micropulse</keyword>
  <keyword>laser</keyword>
  <keyword>subthreshold</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

